BACKGROUND AND PURPOSE: Patients with TIA and minor stroke are at high risk for recurrent stroke. Obstructive sleep apnea (OSA) may increase this risk. The objectives of our study were to determine the prevalence and severity of OSA and its clinical presentation in this population. METHODS: Patients who presented with TIA and minor stroke completed a questionnaire and nocturnal cardiopulmonary monitoring to diagnose OSA and associated nocturnal hypoxia. RESULTS: Sixty-six patients completed the study; 62% had OSA (respiratory disturbance index > 5). Forty-four percent of these patients had moderate or severe OSA (respiratory disturbance index > 15) that was associated with significant nocturnal hypoxia. Most patients did not have the typical clinical features of OSA, such as obesity and daytime sleepiness. CONCLUSIONS: Patients who experience TIA and minor stroke have a high prevalence of OSA and associated hypoxia. The atypical clinical presentation of OSA in this patient population may lead to under-recognition and treatment. Further studies are required to determine the impact of treating OSA on the risk of recurrent stroke.
BACKGROUND AND PURPOSE:Patients with TIA and minor stroke are at high risk for recurrent stroke. Obstructive sleep apnea (OSA) may increase this risk. The objectives of our study were to determine the prevalence and severity of OSA and its clinical presentation in this population. METHODS:Patients who presented with TIA and minor stroke completed a questionnaire and nocturnal cardiopulmonary monitoring to diagnose OSA and associated nocturnal hypoxia. RESULTS: Sixty-six patients completed the study; 62% had OSA (respiratory disturbance index > 5). Forty-four percent of these patients had moderate or severe OSA (respiratory disturbance index > 15) that was associated with significant nocturnal hypoxia. Most patients did not have the typical clinical features of OSA, such as obesity and daytime sleepiness. CONCLUSIONS:Patients who experience TIA and minor stroke have a high prevalence of OSA and associated hypoxia. The atypical clinical presentation of OSA in this patient population may lead to under-recognition and treatment. Further studies are required to determine the impact of treating OSA on the risk of recurrent stroke.
Authors: Emerson M Wickwire; M Doyinsola Bailey; Virend K Somers; Mukta C Srivastava; Steven M Scharf; Abree M Johnson; Jennifer S Albrecht Journal: Sleep Breath Date: 2020-11-03 Impact factor: 2.816
Authors: Emerson M Wickwire; Sarah E Tom; Aparna Vadlamani; Montserrat Diaz-Abad; Liesl M Cooper; Abree M Johnson; Steven M Scharf; Jennifer S Albrecht Journal: J Clin Sleep Med Date: 2019-12-05 Impact factor: 4.062
Authors: Emerson M Wickwire; M Doyinsola Bailey; Virend K Somers; Liesl M Oldstone; Mukta C Srivastava; Abree M Johnson; Steven M Scharf; Jennifer S Albrecht Journal: J Clin Sleep Med Date: 2022-01-01 Impact factor: 4.062